Steady state BE study dosing [Design Issues]

posted by dshah  – India, 2024-01-22 11:09 (425 d 11:01 ago) – Posting: # 23837
Views: 3,103

Hi NK!

❝ Kindly clarify, whether 2nd and 3rd dose on day 5 need to be administered or not? and sampling should be continued for 24 hours?


So you are asking for protocol preparation consideration. The study is in healthy volunteers- so I believe that AUC0-t/AUC0-inf>=0.8 also needs to be followed, so consider sampling accordingly.

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,670 registered users;
20 visitors (0 registered, 20 guests [including 3 identified bots]).
Forum time: 22:10 CET (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5